Explore more publications!

Press Releases

Scientists Develop a New Metal Implant That Supports Healing While Slowly Degrading
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm
MNR University Earns DASCA Accreditation, Advancing Industry-Aligned Education in Data Science & AI
ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
Integrative experiment design reveals hidden patterns in decades-old social science research
The Subatomic Kid Takes Readers on a Mind-Bending Adventure Story Through Science, Identity, and Power
The Science Behind Glycocalyx Support: Why Rhamnan Sulfate Is Different
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
Global Breast Cancer Diagnostics Market 2026–2036: Regional Dominance & Key Players like Roche, Thermo Fisher Scientific
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
BDC launches a $150‑million Life Sciences Venture Fund
Retired Air Force Captain Allan Hogan Bridges Science and Faith in New Memoir on Human Unity
Health Sciences Complex at Hinds to Add 480 Training Seats for Mississippi’s Healthcare Workforce

Health Sciences Complex at Hinds to Add 480 Training Seats for Mississippi’s Healthcare Workforce

BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
BSX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
GlucoZen (2026 CONSUMER REPORT): The “Glucose Ritual” Formula Driving Interest in Natural Blood Sugar Support, Ingredient Science, Pricing, and What Consumers Should Know
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
MUS Immersive and Toro Science Accelerate the Commercialization of Immersive Cinematic Experiences
ROOT Brands® Addresses the GLP-1 Gap with CRUSH and SCULPT, a Science-Driven Protocol for Metabolic and Muscle Support After Ozempic® and Wegovy®

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions